CLINICAL_TRIALS
trial_result
· 2023-07-17
Clinical Trial Update: Relapse Prevention Study in Patients With Schizophrenia [Phase 3]
Summary
Phase 3 relapse prevention study in schizophrenia has completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Vanda Pharmaceuticals | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2023-07-17